Posted on 272
Desktop Metal, Inc. (NYSE: DM), a leader in mass production and turnkey additive manufacturing solutions, today announced the appointment of James Haley as its new Chief Financial Officer, effective February 12, and Arjun Aggarwal as Chief Product Officer, effective February 9.
“I have previously worked with James and forged a great relationship with him over 13 years. He brings a strong track record of leading financial operations for high-growth technology companies with significant functional experience overseeing strategic transactions and public financing events,” said Ric Fulop, CEO and co-founder of Desktop Metal. “James has already proven to be a strong addition to our leadership team, and I am excited to work with him closely in his new role to drive our success and deliver value for our shareholders.”
2 months ago
GAAP net income per diluted share increased 10% to $1.57
GAAP net cash provided by operating activities for the nine-months ended December 31, 2020 increased 79% to $787.7 million
Adjusted Unrestricted Operating Cash Flow (Non-GAAP) for the nine-months ended December 31, 2020 increased 56% to $854.3 million
Net Bookings were $814.3 million
Company again raises outlook for fiscal year 2021, including record Net Bookings
NEW YORK–(BUSINESS WIRE)–Take-Two Interactive Software, Inc. (NASDAQ: TTWO) today reported strong results for its fiscal third quarter 2021 ended December 31, 2020. In addition, the Company provided its initial outlook for its fiscal fourth quarter ending March 31, 2021 and again increased its outlook for the fiscal year 2021, ending March 31, 2021. For additional information, please see the fiscal third quarter 2021 results slide deck posted to the Company’s investor relations website at http://ir.take2games.co
Janssen Pharmaceutica NV: Janssen Announces Treatment with ERLEADA?(apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer
FOR EMEA PHARMACEUTICAL TRADE AND MEDICAL MEDIA ONLY NOT FOR DISTRIBUTION IN BENELUX, SWEDEN AND ITALY
Janssen Pharmaceutica NV (Janssen) announced today results from the final analysis of the Phase 3 TITAN study, which demonstrated the continued statistically significant benefit of apalutamide plus androgen deprivation therapy (ADT) in overall survival (OS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) when compared to placebo plus ADT.
1 Results will be featured in an oral presentation at the American Society of Clinical Oncology s Genitourinary (ASCO GU) Cancers Symposium, taking place virtually February 11-13, 2021 (Abstract #11; Rapid Abstract Session: Prostate Cancer, February 11 9:30 PM-10:15 PM CET).
GAAP net revenue was $860.9 million
GAAP net income per diluted share increased 10% to $1.57
GAAP net cash provided by operating activities for the nine-months ended December 31, 2020 increased 79% to $787.7 million
Adjusted Unrestricted Operating Cash Flow (Non-GAAP) for the nine-months ended December 31, 2020 increased 56% to $854.3 million
Net Bookings were $814.3 million
Company again raises outlook for fiscal year 2021, including record Net Bookings
NEW YORK–(BUSINESS WIRE)–Take-Two Interactive Software, Inc. (NASDAQ: TTWO) today reported strong results for its fiscal third quarter 2021 ended December 31, 2020. In addition, the Company provided its initial outlook for its fiscal fourth quarter ending March 31, 2021 and again increased its outlook for the fiscal year 2021, ending March 31, 2021. For additional information, please see the fiscal third quarter 2021 results slide deck posted to the Company’s investor relations website at http://ir.take2games.com.
Share this article
Share this article
YARDLEY, Pa., Feb. 9, 2021 /PRNewswire/ Crown Holdings, Inc. (NYSE: CCK) today announced its financial results for the fourth quarter and full year ended December 31, 2020.
Fourth Quarter and Full Year Highlights
Earnings per share $1.12 for the quarter versus $0.64 in prior year; $4.30 full year versus $3.78 in 2019
Adjusted earnings per share $1.50 for the quarter versus $1.04 in prior year; $5.92 full year versus $5.11 in 2019
Beverage can volumes up 4% for the year
Food can volumes up 7% for the year
Over $1.3 billion in cash from operations
Record adjusted free cash flow of $756 million; more than $1.5 billion over last two years
15 billion units of beverage can capacity commercialized/announced from 2020 to end of 2022